Depression in autism spectrum disorder: a scoping review of pharmacologic, neuromodulation, and psychosocial interventions
IntroductionMajor depressive disorder is common in autism spectrum disorder, but diagnosis and treatment are complicated by symptom overlap, atypical presentations, alexithymia, and limited ASD-specific evidence.MethodsWe conducted a scoping review of PubMed, PsycINFO, and reference lists for studies published from 1995 through 2025 examining pharmacologic, neuromodulation, and psychosocial…
Read original article on Frontiers in Psychiatry | New and Recent Articles →Related news
-
Buffering stress in cognitive aging: the moderating role of positive emotions on trait-level stress reactivity and negative emotions in middle-aged and older adults
Switzerland
-
Association between platelet-to-albumin ratio and major depressive disorder: findings from a Chinese clinical cohort supported by population-based evidence
Switzerland
-
Clinimetric properties of the Chinese version of the subjective incompetence scale: an extended paradigm
Switzerland
-
Integrated bioinformatics analysis identifies a ubiquitination-related gene signature in schizophrenia with peripheral clinical validation
Switzerland
-
Longitudinal trajectories of benefit finding and its associations with emotion regulation, social connectedness, depression, and anxiety among Chinese college students following the removal of COVID-19 restrictions. a multivariate latent growth curve analysis
Switzerland
-
Patterns and clinical outcomes of antidepressant prescribing in children and adolescents: real-world evidence from a mental health hospital in Türkiye
Switzerland
-
Initiative vs. Guilt In Psychosocial Development
United Kingdom
-
Industry vs. Inferiority in Psychosocial Development
United Kingdom